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Pathway sensor-based functional 
genomics screening identifies 
modulators of neuronal activity
Alexander Herholt1,2, Ben Brankatschk2, Nirmal Kannaiyan2, Sergi Papiol  1, 
Sven P. Wichert2, Michael C. Wehr  1 & Moritz J. Rossner1
Neuronal signal transduction shapes brain function and malfunction may cause mental disorders. 
Despite the existence of functional genomics screens for proliferation and toxicity, neuronal signalling 
has been difficult to address so far. To overcome this limitation, we developed a pooled screening assay 
which combines barcoded activity reporters with pooled genetic perturbation in a dual-expression 
adeno-associated virus (AAV) library. With this approach, termed pathScreener, we comprehensively 
dissect signalling pathways in postmitotic neurons. This overcomes several limitations of lentiviral-
based screens. By applying first a barcoded and multiplexed reporter assay, termed cisProfiler, we 
identified the synaptic-activity responsive element (SARE) as top performance sensor of neuronal 
activity. Next, we targeted more than 4,400 genes and screened for modulatory effects on SARE 
activity in primary cortical neurons. We identified with high replicability many known genes involved 
in glutamatergic synapse-to-nucleus signalling of which a subset was validated in orthogonal assays. 
Several others have not yet been associated with the regulation of neuronal activity such as the 
hedgehog signalling members Ptch2 and Ift57. This assay thus enhances the toolbox for analysing 
regulatory processes during neuronal signalling and may help identifying novel targets for brain 
disorders.
Functional genomics screens are the gold-standard for dissecting gene networks at the genome-wide level and 
contribute to target identification and mode-of-action studies in the biomedical field1,2. They are frequently used 
to identify genes with roles in proliferation, cell viability, viral infection, gene-drug interaction, and most recently 
cellular signalling3–6. The development has been mainly driven by cancer-related phenotypes (e.g. proliferation) in 
relatively easy accessible huge cell populations7. Unfortunately, these screening protocols are not suitable for the 
study of signalling in postmitotic cell types like primary neurons, as many disease-related neuronal phenotypes 
rely more on cell-to-cell communication (e.g. synaptic transmission) and the formation of complex morphologies 
and networks8. Existing protocols require high cell numbers per individual perturbation to gain sensitivity and 
robustness, but cell numbers are very limited for most primary postmitotic cell types9. The dissection of signalling 
pathways currently requires the dissociation of the cell population for cell sorting or droplet-based single cell 
analysis10. While this was successful in the case of immune cells and neuronal stem cells4,11–14, it is not a favoura-
ble procedure for mature neuronal networks and might generate preparation associated artefacts15. We reasoned 
that a protocol avoiding any trituration followed by cell sorting would greatly facilitate the screening process and 
enable pooled genetic screenings of so far inaccessible cell-types, such as primary neurons.
Neuronal activity-dependent signalling, e.g. modulating local protein synthesis and gene expression, is key to 
higher brain function and disturbed neuronal excitation and signalling has been associated with many brain dis-
eases16,17. While descriptive methods such as proteomics and transcriptomics have delivered insight into the syn-
aptic architecture and neuronal activity-dependent gene expression, respectively8,18,19, the empirical association 
of gene functions with a dedicated neuronal phenotype is a tedious endeavour and high-throughput techniques 
are not yet available. The activity state of neurons has long been visualized using reporter proteins controlled by 
activity-dependent promoters or enhancer elements20–23. We and others have demonstrated that signalling can 
be robustly measured by deep sequencing using pathway-specific reporters expressing short synthetic RNA bar-
code sequences24,25. Thus, we hypothesized that barcoded genetic sensors might provide the required sensitivity 
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to perform comprehensive pooled screens for disturbed signalling in primary neuron cultures. In addition, the 
sensor approach would also circumvent the need for cell trituration and sorting.
As a proof-of-principle, we first identified a top neuronal activity sensor to build a sensor-coupled shRNA 
effector library targeting over 4,400 genes. Next, we applied this screening technology to silenced versus activated 
cortical neuron cultures to identify modulators of synapse-to-nucleus signalling.
Results
Pathway profiling identifies top performance neuronal activity sensor. The sensitivity and robust-
ness of a genetic screen is likely as dependent on the performance and dynamic range of the reporter as in cell-
based compound screens26. Therefore, a panel of 70 cis-regulatory pathway reporters was generated to identify 
a sensor with excellent performance in a given cellular paradigm. The library consists of clustered transcription 
factor binding sites, enhancers, or short promoters coupled to a luciferase reporter and individually to unique 
RNA barcodes which we collectively term cisProfiler (Fig. 1a and Supplementary Table S1). The cisProfiler pool 
was packaged into AAV particles and used to infect postmitotic cortical cultures which were treated either with a 
cocktail including tetrodotoxin (TTX) to silence neuronal activity, or with a cocktail containing bicuculline (BIC) 
raising neuronal activity (Fig. 1b, see Methods for details).
Online monitoring of luciferase activity from the cisProfiler pool revealed a strong increase upon BIC stim-
ulation, while TTX decreased the signal below baseline (Fig. 1c). To identify individual reporters mediating this 
response and in particular those displaying the largest dynamic range between an inactivated and activated state, 
we measured sensor activities by deep sequencing of the RNA barcodes (Fig. 1b) (see Methods for details). We 
identified a cluster of reporters which reacted to silencing and stimulation, containing regulatory elements of 
several prototypical neuronal-activity coupled genes such as Fos and Egr1 among others (Fig. 1d, Supplementary 
Fig. S1, and Supplementary Table S2). Several sensors displayed kinetics with a sustained response, amplified 
response, or transient response, essentially reflecting corresponding categories described for endogenous genes 
induced by neuronal activity27.
The synaptic activity-responsive element (SARE) gave the largest dynamic range 4 hrs after BIC stimulation 
and outperformed classical neuronal activity reporters (Fig. 1d), in line with a previous report28. The SARE region 
is a conserved enhancer of the immediate-early gene Arc, consisting of binding sites for the transcription factors 
CREB, MEF2, and SRF/TCF, which can be found in promoters of multiple neuronal activity-dependent genes 
and is therefore likely integrating transcriptional responses elicited by different neuronal activity-dependent sig-
naling pathways29,30. Given the high fold-change activation and well characterized structure of SARE, we decided 
to use this cis-regulatory element for developing the pathScreener assay. A cluster of four SARE repeats proxi-
mal to the 420 bp Arc core promoter (ArcMin) gave maximal dynamic range in luciferase reporter gene assays 
(Supplementary Fig. S2). This reporter is hereafter called E-SARE in accordance to the construct generated by 
Kawashima and colleagues and was subsequently used as final sensor element28.
Construction of the AAV pathScreener library by sensor-effector coupling. Instead of a lentiviral 
screening vector, we used the AAV system as it has certain advantages. AAV particles have a natural tropism for 
neuronal cells and do not elicit cytotoxicity31. In addition, AAV-based systems have been extensively investigated 
for human gene therapy purposes and the availability of many natural as well as synthetic capsid proteins allows 
broad applications in many different tissues and cell types32. Furthermore, the AAV genome persists extrachro-
mosomally which avoids effects on reporter performance depending on the genomic locus as with integrated 
lentiviruses. The AAV screening vector presented here was designed as a dual-expression vector containing the 
E-SARE reporter (=sensor component) and the shRNA cassette (=effector component) in opposing directions 
yielding the final sensor-effector coupled design (Fig. 2a). The E-SARE reporter is driving the expression of the 
Firefly luciferase (luc2) and a 35 bp barcode sequence (BC) in response to neuronal activity as in the cisProfiler 
assay (Fig. 1). The shRNA is constitutively expressed by a human U6 promoter, which performed better compared 
to neuronal promoters (Supplementary Fig. S3). We verified that the proximity of the shRNA expression cassette 
does not affect the E-SARE sensor performance (Supplementary Fig. S4). Run-through transcripts from the hU6 
promoter due to insufficient termination have been a concern, as they would bias the barcode pool for sequencing 
if transcribed into cDNA33. A comparison of random primers with oligo(dT) primers for cDNA synthesis indi-
cated that the oligo(dT) primers are superior in this set-up and we show that transcriptional run-through by RNA 
polymerase is not interfering with the assay (Supplementary Fig. S4).
We used a shRNA collection focused on 4,625 signalling pathway targets as template for library construction 
(see Methods for details). The shRNA cassette was amplified, extended by a short synthetic poly-adenylation sig-
nal (SpA) and a semi-random barcode sequence and cloned into the AAV vector containing the E-SARE reporter 
cassette (Supplementary Fig. S5). The proximity of barcode and shRNA within a window of less than 400 bp 
allowed assigning each shRNA with its barcode by deep sequencing (Supplementary Fig. S5) recovering ~97% of 
all target genes (see Methods for details).
Pooled genetic interference screen in postmitotic cortical cultures. Within the library, the neu-
ronal activity-dependent E-SARE sensor controls the expression of a multitude of unique RNA barcodes. Each 
barcode is linked to a specific shRNA expressed from the same AAV vector (Fig. 2a). Thereby, deep sequencing of 
the barcode pool during screening is sufficient to identify the corresponding shRNA and to measure the sensor 
activity simultaneously. We performed two screens with 2–3 replicates per condition. For each replicate sample, 
10 or 5 million primary cortical neurons plated on 15 or 10 cm dishes, termed screen A and B respectively, were 
infected with the AAV library pool at an infection rate of ~60% at day-in-vitro (DIV) 6 avoiding multiple infec-
tions per cell (Supplementary Fig. S6). The maturation of the neuronal network was continued until DIV12 to 
allow formation of active synapses and spontaneous network activity34,35. Half of the cultures were subsequently 
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silenced using a TTX cocktail to reduce the E-SARE activity to baseline level to quantify the relative abundance 
of each functional library vector. In the remaining cultures, network activity was stimulated by a BIC cocktail 
in order to reveal genes which participate in neuronal activity-dependent signalling (see Methods for details). 
From each sample, total RNA was purified, and barcode pools were prepared for deep sequencing. The effect of 
each gene knockdown on E-SARE activity was determined by comparing all barcodes of the stimulated samples 
with each other after normalization to the silenced reference samples (Fig. 2b). It was expected that a knock-
down of a positive regulator of activity-dependent neuronal signalling will decrease the relative E-SARE activity, 
whereas a knockdown of a negative regulator will increase the relative E-SARE activity. The induction of the 
E-SARE activity upon stimulation of synaptic activity by BIC was monitored in sister cultures by live cell online 
luciferase recordings (21 fold-change, BIC vs TTX) (Fig. 2c,d). The induction of barcode expression from the 
Figure 1. Pathway profiling in cortical neurons: Selection of a high-performance neuronal activity sensor. 
(a) Schematic map of the AAV cisProfiler vectors, used to simultaneously monitor multiple signalling events 
in neurons. See Supplementary Table S1 for details. (b) Workflow for the cisProfiler assay in primary cortical 
neurons. (c) Continuous live-cell recordings of the cisProfiler response in primary cortical neurons (DIV11–13) 
upon treatment with TTX cocktail (1 µM TTX, 100 µM APV) or BIC cocktail (50 µM BIC, 100 µM 4-AP, 100 µM 
glycine, 1 µM strychnine). Recording was performed in parallel to the assay shown in (d). (d) cisProfiler sensor 
responses at the indicated time points in primary cortical neurons as log2 fold-changes between treated (BIC, 
TTX) and untreated samples, measured by barcode sequencing. Sensors are ranked by the dynamic range 
between 4 hrs BIC cocktail stimulation and TTX cocktail treatment (timepoint used for pathScreener assay). 
Workflow as shown in (b). Treatment conditions as in (c). See Supplementary Table S2 for details. ITR, inverted 
terminal repeat; minMLP, minimal Major Late Promoter; BC, barcode; WPRE, Woodchock hepatitis virus 
posttranscriptional regulatory element; pA, poly-adenylation signal. BIC, bicuculline; TTX, tetrodotoxin; APV, 
(2R)-amino-5-phosphonovaleric acid; (2R)-amino-5-phosphonopentanoate; 4-AP, 4-Aminopyridine.
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E-SARE reporter in the actual screening samples was also controlled using relative quantification by qRT-PCR of 
all barcodes in the library (29 fold-change, BIC vs TTX) (Fig. 2e). Normalized read counts of replicate samples 
from two screens (‘A’ with 10 million and ‘B’ with 5 million cells per sample) highly correlated within conditions, 
highlighting the robustness of the screening technology (Pearson correlation coefficient ρ > 0.985 BIC; ρ > 0.972 
Figure 2. Pooled sensor-effector coupled interference screen in cortical neurons. (a) Schematic map of the 
pathScreener library vector. (b) Workflow for the pathScreener experiments in primary cortical neurons.  
(c) Continuous live-cell recordings of the pathScreener library response in primary cortical neurons (DIV12) 
upon treatment with TTX cocktail (1 µM TTX, 100 µM APV) or BIC cocktail (50 µM BIC, 100 µM 4-AP, 100 µM 
glycine, 1 µM strychnine). Recording was performed in parallel to screen A/B. n = 3, ±s.e.m. ***p < 0.001 
(Two-way ANOVA). (d) Maximal E-SARE sensor induction during live-cell recording shown in (c). n = 3, 
±s.e.m. *p < 0.05 (Two-tailed T-Test). (e) Relative barcode expression from pathScreener library in screen A 
after treatment with TTX cocktail for 48 hrs or BIC cocktail for 4 hrs. n = 2–3,±s.e.m. p = 0.06 (Two-tailed 
T-Test). (f) Pair-wise correlation of normalized read counts from biological replicates of screen A and B. 
Unsupervised hierarchical clustering. (g) Enhanced Z-score ranking for individual shRNAs from screen A. 
Enhanced Z-score threshold of ±3 is indicated by a dashed line. (h) DESeq2 analysis of screen A at shRNA 
level. MA-plot output comparing the sensor response for each shRNA within the library (log2 fold change: 4 
hrs BIC cocktail vs. TTX cocktail; y axis) with the mean sensor expression (x axis). shRNAs with a significantly 
deregulated sensor expression (FDR < 0.1) are shown in red/blue. (i) Overlap between top 100 hit lists for 
positive regulators from screen A and B. Analysis by DESeq2 (top) or enhanced Z-score ranking (bottom). 
ITR, inverted terminal repeat; luc2, firefly luciferase; BC, barcode; pA, poly-adenylation signal; T6, terminator; 
shRNA, short hairpin RNA; hU6p, human U6 promoter. BIC, bicuculline; TTX, tetrodotoxin; APV, (2R)-
amino-5-phosphonovaleric acid; (2R)-amino-5-phosphonopentanoate; 4-AP, 4-Aminopyridine. DIV, day- 
in-vitro. s.e.m., standard error of the mean.
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TTX) (Fig. 2f). These results also indicate that the screening coverage may be further decreased below 250 cells 
per individual shRNA, as applied in screen B, which is far below the suggested coverage needed for Lentiviral 
screens with >103 cells per construct9.
We used an enhanced Z-score ranking (ZS) and the Bioconductor DESeq2 package as two independent anal-
ysis methods for hit nomination (Table 1, Supplementary Table S3)4,36. Rankings from the two analysis meth-
ods were highly correlated (Spearman rank coefficient rho > 0.972, Screen A/B; Supplementary Fig. S7) and we 
observed a considerable number of shared hits among the top 100 positive regulators (54/100, p < 10−10, hyperge-
ometric test; Supplementary Fig. S7). In both approaches, more shRNAs scored for positive regulators of neuronal 
activity, thus reducing the E-SARE activity (Screen A ZS: 209 vs. 111 shRNAs, cutoff at enhanced ZS ± 3; DESeq2: 
335 vs. 250 shRNAs, cut-off at FDR < 0.05) (Fig. 2g,h, and Supplementary Fig. S7). Overall, hit gene rankings 
from screen A and B are correlated (Spearman rank coefficient rho = 0.567; Supplementary Fig. S7), with a sub-
stantial overlap for the top 100 positive regulators between the replicate screens (45/100 for enh. ZS, 55/100 for 
DESeq2, p < 10−10, hypergeometric test; Fig. 2i). The assay in the current setup was less sensitive for negative reg-
ulators likely due to the strong and nearly saturating stimulation by the BIC cocktail, which was reflected by less 
primary negative regulator hits and a smaller overlap between individual screens (15/100 for enh. ZS, p < 10−8, 
hypergeometric test; Fig. 2g,h, and Supplementary Fig. S7).
pathScreener identifies genes involved in neuronal signalling and brain disorders. In order 
to systematically interpret the screening results, we tested for pathway enrichment in manually curated gene 
sets from Reactome and KEGG databases37,38. For the top-ranked positive regulators, the Reactome categories 
“Ca-dependent events”, “CaMK IV-mediated phosphorylation of CREB”, and “Activation of NMDA receptor upon 
glutamate binding and postsynaptic events” (all p < 0.003 and false discovery rate [FDR] q val < 0.05; Fig. 3a, 
and Supplementary Table S4), as well as the KEGG pathway categories “Long-term potentiation”, “Neurotrophin 
signaling”, and “Calcium signaling” (all p < 0.05, hypergeometric test; Supplementary Table S5) were identified 
amongst others related to synapse-to-nucleus signalling.
Based on a cut-off at an enhanced ZS of −2, we next selected ten high, mid, and low-ranking genes from 
the list of positive regulators and cloned the corresponding shRNA of each candidate individually into the 
dual-expression vector (Fig. 3b). For each construct, AAVs were generated and neurons were infected on 
DIV6 followed by cell lysis and luciferase assays on DIV12 as for the primary screen. Among these candidate 
Gene symbol Refseq ID Enh. ZS
DESeq2
log2FC p-value p-adj
Vegfa NM_001025250 −11.01 −0.913 2.77E-10 NA
Adcy3 NM_138305 −9.87 −1.430 9.35E-23 1.67E-19
Il2rb NM_008368 −9.34 −1.399 1.68E-22 2.58E-19
Igfbp6 NM_008344 −9.07 −1.119 1.22E-13 8.21E-11
Camk2d NM_001025439 −8.71 −1.343 3.29E-21 4.42E-18
Cyp3a13* NM_007819 −8.59 −0.707 1.36E-06 NA
Cflar NM_207653 −8.46 −1.028 1.02E-11 4.57E-09
Fgf18* NM_008005 −8.23 −0.413 2.57E-08 5.73E-06
Cox15* NM_144874 −7.58 −1.320 2.09E-24 7.49E-21
Dnajb1 NM_018808 −7.48 −0.653 9.79E-06 NA
Hr NM_021877 −7.45 −0.219 3.00E-02 2.09E-01
Ptch2* NM_008958 −7.36 −0.808 9.44E-08 1.75E-05
Adh1* NM_007409 −7.25 −1.048 8.12E-13 4.59E-10
Il27 NM_145636 −7.17 −0.601 4.01E-05 NA
Araf* NM_009703 −6.88 −0.521 9.35E-06 NA
Dpysl2 NM_009955 −6.79 −0.818 6.52E-08 1.30E-05
Mapk14 NM_011951 −6.57 −1.249 5.51E-28 3.00E-24
Krt18* NM_010664 −6.55 −0.921 4.24E-10 1.52E-07
Dot1l* NM_199322 −6.23 −0.870 4.11E-09 1.13E-06
Pigm* NM_026234 −5.81 −0.795 8.89E-08 1.70E-05
Xcr1* NM_011798 −5.73 −1.096 5.85E-23 1.26E-19
Cyp19a1 NM_007810 −5.71 −0.573 1.38E-04 6.49E-03
Ift57* NM_028680 −5.67 −0.981 5.84E-14 4.47E-11
Apbb2* NM_009686 −5.42 −0.416 3.69E-03 NA
Ppp5c NM_011155 −5.41 −0.551 2.52E-04 NA
Table 1. Top 25 positive regulator hits. Top 25 Hits ranked by enhanced Z-score (Enh. ZS) along with 
corresponding log2 fold change values (log2FC) and unadjusted (Wald statistics) and adjusted p-values 
(Benjamini-Hochberg) from the DESeq2 analysis. Gene Symbols marked with * have not yet been associated 
with neuronal signalling according to a detailed PubMed search (see below). NA, adjusted p-value could not be 
calculated. Continued in Supplementary Table S3.
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shRNAs, eight significantly reduced the SARE-driven luciferase activity upon BIC stimulation compared to the 
non-targeting control (NTC) vector (all p < 0.05). Knockdown of the two L-type Ca-channel units CACNA1F 
and CACNA1H revealed lower levels of reductions with effects close to significance (p = 0.05 and 0.09, respec-
tively) (Fig. 3b).
From the above validated candidates, we further focused on adenylate cyclase 3 (Adcy3), gephyrin (Gphn) 
and the alpha 1F subunit of the voltage-dependent L-Type calcium channel (Cacna1f) and cloned corresponding 
shRNAs into a dual-expression AAV backbone allowing to assess Ca2+-imaging via the GCaMP5G reporter as 
an orthogonal validation assay (Fig. 3c). Knockdown of Adcy3 and Gphn reduced BIC-induced Ca2+ release 
compared to a non-targeting control (NTC) vector significantly (p < 0.001). Again, the shRNA directed against 
the L-Type calcium channel Cacna1f revealed the most moderate effect (Fig. 3b) which was congruent with the 
observed knockdown effects assessed by qRT-PCR (Supplementary Fig. 8). Finally, we re-applied the cisProfiler 
assay to monitor the consequence of Adcy3, Gphn and Cacna1f knockdowns compared to Ca2+-depletion medi-
ated by BAPTA in neurons (Supplementary Table S6). Unsupervised clustering of all pathway reporter responses 
revealed graded effects of all three candidates on multiple neuronal activity sensors (e.g. EGR1, FOS, Npas4, 
BDNFpI) with knockdown of Adcy3 showing the most pronounced suppression of reporter activities followed by 
Gphn and Cacna1f, in line with the GCaMP results (Fig. 3d).
Figure 3. Orthogonal validation of selected primary hits. (a) Reactome pathway analysis of top 150 positive 
regulator hits from screen A based on Z-score ranking. Notably, multiple terms related to synapse-to-nucleus 
signalling are among the top categories (bold). (b) Individual validation of selected hit shRNAs in E-SARE 
luciferase assay. All tested shRNAs reduced E-SARE activity relative to the non-targeting control (NTC). Same 
cell culture paradigm as in screens A/B (Fig. 2b). n = 3, ±s.d. ***p < 0.001; ***p < 0.01; *p < 0.05 (Two-tailed 
T-Test). (c) Effect of Adcy3, Gphn, and Cacna1f knockdown on calcium dynamics after stimulation with BIC 
cocktail, measured using GCaMP5G. Number of cells in parenthesis. Normalized mean intensity values ± s.e.m. 
***p < 0.001 (Two-way ANOVA). (d) Effect of Adcy3, Gphn, and Cacna1f knockdown on multiple signalling 
pathways measured using the cisProfiler library. Cortical cultures infected with hit shRNAs were stimulated 
with BIC cocktail (BIC) for 4 hr. For comparison, the heatmap also shows profiles of silences cultures (TTX) and 
cultures were calcium signalling was abolished (BAPTA). Responses were normalized to non-targeting control 
(shNTC) samples stimulated with the BIC cocktail. See Supplementary Table S6 for details. BIC, bicuculline; 
TTX, tetrodotoxin; BAPTA, 1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid; s.e.m., standard error 
of the mean; s.d., standard deviation.
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Finally, we visualized the topology of the top-ranked positive regulators in an extended protein-protein inter-
action network, where most candidates (106/130, 82%) were connected in a tight cluster indicating functional 
relationships (Fig. 4a). A high proportion of these hits are associated in the literature with MeSH terms related 
to neuronal signalling such as ‘synaptic transmission’, ‘neuronal plasticity’, or ‘long-term potentiation’ (59/130, 
45%; Fig. 4b) or mental disorders like “Schizophrenia Spectrum and Other Psychotic Disorders” (53/130, 40%; 
Fig. 4c) (see Methods for all details of the PubMed query). Nonetheless, for a reasonable number of candidates no 
literature association was found. These include for example the hedgehog signalling components Ptch2 and Ift57, 
as well as multiple chemokine signalling members (Cxcr5, Ccr5, Cxcl2, Xcr1) which ranked among the top hits 
(Table 1, Supplementary Table S3).
We conclude from these analyses that the pathScreener assay can identify known and novel players of neu-
ronal signalling with high confidence and provides an empirical tool to characterize components of complex 
signalling pathways.
Figure 4. Network visualization of top primary hits. (a) Network visualization of top positive regulator hits 
from screen A identifies one main cluster connected by multiple protein-protein interactions as well as several 
unconnected hits. Gene names are shown as node titles. Node size reflects enhanced Z-score values. Edges 
represent known protein-protein interactions (Cytoscape/Bisogenet) and interactions with one additional 
interactor are shown (see Methods for details). (a,c) Network as in a, highlighting genes (orange nodes) 
that belong to Reactome pathway categories related to synapse-to-nucleus signalling (b, refers to Fig. 3a, see 
Supplementary Table S4) or those referenced in PubMed with MeSH terms related to neuronal signalling (see 
Methods for details on PubMed query) (c).
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Discussion
The technical challenges of functional genomics screens in primary neurons following standard, abundance-based 
protocols are indicated by a recent small scale CRISPR/Cas9 screen where small effect sizes and low replicate 
correlations were reported39. In contrast, we could show that the design of sensor-effector coupling gives sen-
sitive and robust readouts, leading to a high degree of reproducibility across screens and avoiding any cell sort-
ing induced bias15. Nonetheless, Kramer et al. identified so far unknown modulators of amyotrophic lateral 
sclerosis-related neurodegeneration, highlighting the importance of genomics screens in neuronal systems. With 
the increasing interest in primary cell cultures for functional genomics screens, the aspects of cell heterogeneity 
as well as network- versus cell-intrinsic effects are new topics to the field and require consideration during data 
interpretation. This is of importance for neuronal cultures where many cells (and different cell types, see below) 
interact and modulate each other. A pooled screen with a neuronal network is always limited to cell-intrinsic 
effects of the genetic interference, as only a fraction of cells will have a certain gene-specific phenotype. However, 
during orthogonal validation it is possible to discriminate between cell-intrinsic and network level effects by 
infecting at low versus high titers and analysing shRNA and non-shRNA infected neurons with control condi-
tions. Cell heterogeneity leads to screening results that are rather generic across all cell types within a culture. This 
also applies to the primary mouse cultures used here, even though most cells are excitatory neurons. To allow a 
more precise cell type focused analysis, the pathScreener approach could be combined with a genetic label such 
as Cre-recombinase or FACS purified cell populations.
With over 4,400 targets included within our library, it allowed us to screen an unprecedented number of genes in 
primary cortical neurons and to retrieve many known and unknown modulators of neuronal activity. Notably, we 
successfully screened at much lower cell numbers per shRNA than the standard for pooled screens (250 vs >1,000 
cells per shRNA/sgRNA). Despite this low cell to shRNA ratio, replicate correlations were outperforming those of 
a FACS-based signalling screen in dendritic cells and those of the above mentioned toxicity screen in neurons4,39.
The reproducibility and depth of the network deconvolution are likely to be further increased using CRISPR/
Cas9 libraries. Side-by-side comparisons of pooled RNAi and CRISPR/Cas9 screens argue for higher specificity 
and larger effect sizes in the case of CRISPR/Cas940,41. As a trade-off, CRISPR/Cas9 screens essentially depend-
ent on the co-expression of a Cas9 effector-mediating protein (e.g. in neurons) which is not needed for RNAi. 
Nevertheless, RNAi and CRISPR/Cas9 screens should be considered as complementary approaches, as both seem 
to have advantages in identifying distinct classes of genes in certain screening paradigms42. In particular, if func-
tional genomics screens are performed towards drug target identification, a gene knockdown might more likely 
phenocopy a drug action than a knockout5.
This proof-of-concept screen did already identify a reasonable number of primary hits without published 
association with neuronal function or contributions to mental disorders. Among the top hits from both screen 
replicates, we for example found Ptch2 and Ift57 which are members of hedgehog signalling and the intraflagellar 
transport machinery43. These biological processes are well known for their role in primary cilium function during 
nervous system development and axon outgrowth. Still little is known about the role of hedgehog signalling in 
synaptic plasticity44,45. Our screening design was focusing on a time-window where axonal specification and pri-
mary dendrite outgrowth is completed, and synaptogenesis and spine maturation takes place46. The fact that Ptch2 
and Ift57 appear as top hits provide new evidence that hedgehog signalling might also regulate synaptic plasticity 
and neuronal activity. This finding definitively requires thorough follow up validations to be substantiated. Thus, 
among all unreported modulators there might be putative targets for drug discovery to modulate neuronal activ-
ity. Follow-up studies are needed to investigate such candidates and to individually validate their functions.
Taken together, the pathScreener assay allows to down-scale cell culture sizes, making genome-wide screens 
in primary neurons truly feasible. The general strategy presented, i.e. first identifying a top-performance sensor 
from the cisProfiler library, followed by a pathScreener assay to dissect upstream signalling cascades, has the 
potential to be modified towards diverse applications, such as expanding the sensor repertoire for different spe-
cificities and/or cell types towards human cellular disease models.
Methods
All methods were carried out in accordance with institutional guidelines and regulations including animal exper-
iments (breedings of C57bl6 mice for generation of primary neurons) approved by the Regierungspräsidium 
Oberbayern, ROB Munich, Germany under the license Az: 55.2-1-54-2532-179-2016.
Chemicals. Tetrodotoxin citrate (TTX), (−)-Bicuculline methiodide (BIC), 4-Aminopyridine (4-AP), Strychnine 
hydrochloride, Glycine (all Abcam), (2 R)-amino-5-phosphonovaleric acid; (2 R)-amino-5-phosphonopentanoate 
(D-APV) (R&D Systems), Phorbol-12-myristat-13-acetat (PMA), 1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′- 
tetraacetic acid) (BAPTA) (Sigma).
Cell culture. Primary neurons were isolated from cortices of E15.5 C57BL6/N mice from in-house facilities. 
Cortices were dissociated by treatment with Papain suspension (Worthington) and gentle trituration. Cell plating 
was done in Neurobasal medium supplemented with 2% B27, GlutaMax and 5% FBS (all Gibco), on poly-L-lysine 
(MW 70,000–150,000; Sigma) coated plastic tissue culture dishes (BD Falcon) at a cell density of 550–650 cells/mm2. 
On DIV1, plating medium was replaced by Neurobasal medium supplemented with 2% B27 and GlutaMax. 
Cultures were fed for the first time on DIV5/6 and then every 3–4 days.
SH-SY5Y cells (ATCC) were cultured in DMEM (high glucose) supplemented with 10% FBS and GlutaMax 
(all Gibco). PC12 Tet-Off cells (Clontech, termed PC12 cells for simplicity) were cultured in DMEM (low glucose) 
supplemented with 10% FBS, GlutaMax and penicillin/streptomycin (all Gibco). HEK293FT cells (ATCC) were 
cultured in DMEM (high glucose) supplemented with 10% FBS and GlutaMax (all Gibco).
All cells were grown in a humidified incubator (37 °C, 5% CO2).
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AAV production. The production of AAV particles was done following a previously published protocol with 
minor modifications47. In brief, HEK293FT cells were co-transfected with the AAV vector (or library) and the 
pFdelta6 helper plasmid as well as an equimolar mix of the capsid plasmids pH21 and pRV1 (serotype 1 and 2, 
respectively) using polyethylenimin transfection reagent (Polyscience). Cells were lysed by freeze-thaw cycles to 
release the AAV particles and treated with Benzonase (Sigma) to digest genomic DNA. The lysate was cleared 
by centrifugation and filtration through a 0.45 µm syringe filter (Millipore), and finally concentrated using an 
Amicon Ultra-15 centrifugal filter unit (100 kDa membrane cut-off; Millipore) including a PBS wash.
The AAV titer was determined by absolute quantification of DNase-resistant AAV genomic copies (GC) using 
quantitative PCR. Therefore, an AAV stock sample was first treated with TURBO DNase (Invitrogen). After inac-
tivation of the DNase, the AAV capsid was digested by proteinase K (Invitrogen) and AAV genomes were isolated 
by spin column-based purification (Macherey&Nagel). shRNA containing AAVs were quantified with primers 
against the hU6 promoter. All other AAVs were quantified with primers against the WPRE sequence.
In order to estimate the ratio of infectious AAV particles to genomic copies, primary neurons were infected 
with a serial dilution of a GFP expressing AAV. GFP positive and total (DAPI positive) cells were counted to cal-
culate the infection rate for a given multiplicity of infection (MOI) (Supplementary Fig. S6).
Cloning of the cisProfiler library. The AAV cisProfiler cloning vector contains AAV2 ITRs flanking a 
Gateway recombination cassette (Invitrogen) followed by the firefly luciferase ORF (luc2, Promega), the WPRE 
sequence and a BGH polyA signal. MultiSite Gateway recombination (Invitrogen) was used to generate the cis-
Profiler sensor vectors. These vectors exist in two configurations of the MultiSite Gateway cassette, depending 
whether the sensor is an endogenous promoter or a clustered cis-element:
Endogenous promoter: attB1_stuffer_attB4r_promoter_attB3r_barcode_attB2
Clustered cis-element (incl. enhancer): attB1_cis-element_attB4r_MLP_attB3r-barcode-attB2
cisProfiler sensor sequences were PCR amplified from a genomic DNA template or synthesized (Genscript) 
and cloned into a pDONR shuttle vector (Invitrogen) (see Supplementary Table S1 for details). The remaining 
pDONR vectors for the MultiSite Gateway recombination contain a stuffer sequence, or the adenovirus major late 
promoter (MLP), or a 49mer barcode library. The barcode design has been previously described24. After MultiSite 
Gateway recombination, each AAV cisProfiler vector has been verified individually by Sanger sequencing and 
three distinct barcode replicates were selected per sensor and included into the cisProfiler library with few excep-
tions (Supplementary Table S1). Vectors with only the MLP, but no sensor, were included as internal calibrators. 
For the cisProfiler assays, the library has been packaged into AAV particles as a pool.
cisProfiler assay. The cisProfiler assay was conducted with primary cortical neurons. Per assay, 5 ∗ 105 cells 
were plated and infected with the AAV cisProfiler library on DIV5 at a MOI of 2,500. A duplicate sample was 
silenced with 1 µM TTX and 100 µM APV at DIV12. On DIV14, a duplicate sample was harvested as an untreated 
reference. The remaining samples were stimulated with 50 µM bicuculline, 100 µM 4-AP, 100 µM strychnine and 
100 µM glycine (BIC cocktail) for 2, 4, and 8 hours in duplicates. All samples were finally harvested in QIAzol 
reagent (Qiagen) and the total RNA was purified using the Direct-zol RNA MiniPrep kit (Zymo). The purified 
RNA was treated with TURBO DNase (Invitrogen) to digest residual AAV genomes and cleaned up by a second 
spin-column purification using the Direct-zol RNA MiniPrep kit according to the manufacturer’s instructions.
Total RNA was reverse transcribed into cDNA using the SuperScript III RT (Invitrogen) and random nonamer 
primers. The barcode sequences were amplified by PCR with barcode flanking primers (Dec_fwd and Dec_rev). 
In a second round of PCR, the Ion Torrent adapter Ion-A and a 12 bp sample barcode was added to the 5′ end and 
the Ion Torrent adapter Ion-P1 to the 3′ end. All PCRs were performed with HotStar Taq plus DNA polymerase 
(Qiagen). The PCR products for each sample were verified by agarose gel-electrophoresis, pooled and purified 
using the NucleoSpin Gel and PCR Clean-up kit (Macherey&Nagel).
The pooled barcode sample was sequenced on an Ion Torrent PGM sequencer (Life Technologies) according 
to the manufacturer’s protocols. Processing of the raw data was done using custom shell and R scripts. Raw reads 
were first split into individual samples using the 12 bp sample barcode. Next, reads were aligned to a reference 
barcode library using a local BLAST. For analysis, read counts were first normalized to total reads per sample and 
then to the read counts of the MLP-only control vectors. The normalized read counts of the barcode replicates per 
sensor were averaged first and then the average of the sample replicates was calculated. Finally, data was presented 
as log2-transformed fold changes relative to the reference sample.
Nonparametric Mann–Whitney test was applied to compare TTX and BIC groups at the different time points 
analysed in these experiments (T2, T4, T8) using IBM SPSS Statistics v22 (IBM SPSS, Statistics for Windows, 
Version 220. IBM Corp.: IBM Corp: Armonk, NY, USA, 2013). Multiple testing correction was carried out 
using false discovery rate (FDR). The p.adjust() function in R 3.2.1 software (R Core Team, R: A Language and 
Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2015) was used 
for this purpose. See Supplementary Table S2 for the cisProfiler statistics.
Live-cell luciferase assay. Live-cell luciferase recordings were performed as quality controls during 
cisProfiler- and pathScreener assays48. 5 ∗ 105 primary cortical neurons were seeded in 3.5 cm tissue culture dishes 
and cultured in a LumiCycle 32 apparatus, inside a non-humidified incubator (37 °C, 5% CO2). The cell culture 
medium was supplemented with D-luciferin (Promega). Cultures were treated according to the experimental par-
adigm of the cisProfiler- or pathScreener assay. Two-way ANOVA was applied for statistical analysis (GraphPad 
Prism).
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Multiplate luciferase reporter gene assay. For multiwell-plate assays, cells were seeded into 96-well 
plates and either transfected (for cell lines) or infected (for primary neurons). Cells were transfected using 
Lipofectamine2000 (Invitrogen) according to the manufacturer’s instructions or infection by an E-SARE-luciferase 
containing AAV. Infection was done with 500–1,000 AAV GCs per cell.
Validation of individual shRNAs was done with primary neurons in 24-well plates. Neurons were infected 
with AAV pathScreener vectors either expressing a shRNA or a non-targeting control RNA. Cultures were treated 
the same way as the screening samples (BIC cocktail vs. TTX cocktail). At the end of the assay, cells were lysed 
using Passive lysis buffer (Promega). The luciferase activity was measured by a Mithras LB 940 Microplate Reader 
(Berthold Technologies)26. Two-sided Student’s T-Test was applied for statistical analysis.
pathScreener vector construction. The pathScreener library cloning vector contains AAV2 ITRs, 
flanking the sensor and effector cassettes. The sensor cassette comprises of a multiple cloning site (MCS) for 
sensor insertion, followed by the firefly luciferase ORF (luc2, Promega), the barcode cassette and a synthetic 
poly-adenylation signal (SpA)49. The effector cassette, which is in the reverse orientation, harbours the human U6 
(hU6) promoter, a stuffer sequence for shRNA insertion, and a T6 terminator sequence.
The E-SARE sensor was cloned into the MCS using KpnI and HindIII sites. Test shRNAs were cloned down-
stream of the hU6 promoter using AgeI and EcoRI sites. To examine interference between the sensor and the 
effector cassette, sensor or effector deletion vectors were cloned (Supplementary Fig. S4). Therefore, either the 
E-SARE sensor or the hU6p-shRNA cassette was excised with KpnI/HindIII or ClaI/EcoRI, respectively, and cut 
sites were blunted using T4 DNA Polymerase and re-ligated.
pathScreener library construction. For construction of the pathScreener library, we used the DECIPHER 
shRNA Mouse Module 1 library (Cellecta) as a template. This library has an optimized shRNA design and is 
focused on 4,625 signalling pathway targets. It contains 5–6 shRNAs per target. The insert for library cloning was 
prepared by two rounds of PCR. In the first PCR, the hU6p-shRNA cassette from the DECIPHER library was 
fused to an oligo containing the synthetic poly-A signal (library_SpA oligo) and amplified by flanking primers 
(library_Dec_rev/library_hU6_fwd). Next, an oligo with a 35 bp semi-random barcode (library_BC35 oligo) was 
fused by PCR to the purified PCR product of PCR#1 and amplified with flanking primers (library_hU6_fwd/
library_BC_rev). The resulting insert was cut with BamHI and ClaI and spin-column purified.
The pathScreener vector, containing the E-SARE sensor, was cut with the same restriction-enzyme pair and 
the linearized vector was first purified by agarose gel-extraction using the NucleoSpin Gel and PCR Clean-up 
kit (Macherey&Nagel). In addition, the vector was purified by phenol/chloroform extraction and ethanol 
precipitation.
Library insert and linearized pathScreener vector were ligated using T4-ligase. Due to the short 2 bp overhang 
at the ClaI site, ligation was slightly modified according to a published protocol for enhanced 2 bp overhang 
cloning50. In brief, the vector/insert mix was heated to 55 °C and subsequently frozen at −20 °C before overnight 
ligation at 16 °C.
shRNA-barcode assignment by deep sequencing. In order to assign the barcode sequence to the 
shRNA, the region encoding the barcode and the shRNA was amplified by PCR using primers with Ion Torrent 
sequencing adapters (PGM_A_IXcode3_AFA_s / PGM_trP1_hU6_as). The PCR product has a size of 345 bp 
and was sequenced on an Ion Torrent PGM sequencer using the 318 chip and the Ion PGM Template OT2 400 
Kit (Life Technologies) for 400 bp read length. Sequencing was done according to the manufacturer’s proto-
cols. The analysis and assignment of barcode sequences to shRNAs was finally done using custom R scripts. See 
Supplementary Table S7 for shRNA sequence information.
Interference screens with pathScreener library. Cell culture. Primary cortical neurons from 16 
embryos were pooled per screen. Per sample, 10 or 5 million cells were seeded onto PLL-coated 15 cm or 10 cm 
tissue culture dishes, respectively. In parallel, PLL-coated 3.5 cm dishes were seeded with 5*105 cells to monitor 
the treatments using the Lumicycler. 2–3 replicate cultures were prepared per treatment condition. On DIV6, 
cultures were infected with the AAV pathScreener library at MOI 1,000. On DIV10, half of the cultures were 
treated with 1 μM TTX and 100 μM APV (TTX cocktail) to silence neuronal activity. The cultures for live-cell 
luciferase recordings were in addition supplemented with the firefly luciferase substrate D-luciferin (Promega) 
and the recording using the Lumicycler was started. On DIV12, the cultures which have not been silenced were 
stimulated with a cocktail containing 50 μM BIC, 100 μM 4-AP, 100 μM glycine, 1 μM strychnine (BIC cocktail) 
for 4 hours.
Harvest. All cultures were lysed after a PBS wash with QIAzol cell lysis reagent (Qiagen) (5 ml for 15 cm dishes, 
2.5 ml for 10 cm dishes). Cell lysate was scraped from the dishes and transferred into a 15 ml tube. The lysate was 
kept at −80 °C until RNA isolation.
Total RNA isolation. Cell debris in the lysate was pelleted by centrifugation at 4,000 rpm for 5 minutes. The 
supernatant was transferred into a new 15 ml tube and the total RNA was isolated using the Direct-zol RNA 
MiniPrep kit (Zymo) according to the manufacturer’s instructions with the following modifications. The lysate 
from 10 million cells was split onto 2 RNA purification spin-columns in order to not exceed the RNA binding 
capacity of a column. Elution was done in 50 μl RNase-free H2O per column and the two eluates from 10 million 
cells were pooled afterwards.
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In order to digest traces of co-isolated AAV genomes, total RNA was treated with TURBO DNase (Invitrogen) 
for 30 minutes at 37 °C and subsequently cleaned-up using the Direct-zol RNA MiniPrep Kit (Zymo) for purifica-
tion. One column was used per sample. Elution was in 25 μl RNase-free H2O.
cDNA synthesis. The first-strand cDNA synthesis was done using the SuperScript III reverse transcriptase 
(Invitrogen). The entire total RNA was reverse transcribed in multiple 20 μl reactions containing 5 μg total RNA 
each and using oligo(dT) primer. The reaction protocol was as followed:
5 minutes at 65 °C, followed by 1 minute on ice. Then add per reaction:
Incubate first at 50 °C for 30 minutes, followed by 15 minutes at 70 °C.
Barcode quantification by qRT-PCR. In order to validate the sensor induction during the screen, RNA barcode 
expression was quantified relative to Rpl13a expression. Primer pairs were qDec1.2/qDec2.2 for the barcode and 
qRT-PCR primer for Rpl13a. Analysis was done using the Qiagen Rotor-Gene Software with the ΔΔCt-method 
for relative quantification.
Default qRT-PCR cycling parameters.
Dec PCR. The ‘Dec PCR’ amplifies the barcode from the cDNA sample. Prior to the ‘Dec PCR’, the entire cDNA 
was purified using the PCR clean-up kit (Macherey&Nagel) and eluted with 20 μl elution buffer. Per sample 100 μl 
reactions were prepared, split into 2 × 50 μl reactions for PCR and pooled again afterwards.
PCR parameters: 98 °C 30 sec, 98 °C 10 sec, 59 °C 30 sec, 72 °C 30 sec (20 cycles).
The PCR product was confirmed by 2% agarose gel-electrophoresis.
Code PCR. The ‘Code PCR’ fuses sample specific 12 bp code sequences to the ‘Dec PCR’ product in order to pool 
samples for next-generation sequencing. The forward code primer contains the Ion-A adapter sequence required 
for Ion Torrent sequencing and the 12 bp code sequence. The reverse primer contains the Ion-P1 adapter sequence 
required for Ion Torrent sequencing. Code PCR reaction per screen sample:
PCR parameters: 98 °C 30 sec, 98 °C 10 sec, 58 °C 30 sec, 72 C 30 sec (10 cycles).
The PCR product was confirmed by 2% agarose gel-electrophoresis.
Total RNA 5 µg
Oligo(dT) primer (50 μM) 1 µl
dNTPs (10 mM each) 1 µl
H2O up to 13 µl
5x First-strand reaction buffer 4 µl
DTT (0.1 M) 1 µl
H2O 1 µl
SuperScript III RT 1 µl
2x RotorGene SYBRgreen PCR Master Mix 5 µl
Fwd primer (10 μM) 1 µl
Rev primer (10 μM) 1 µl
cDNA (purified) 10 µl
qDec1.2 fwd primer (10 μM) 1.25 µl
qDec2.2 rev primer (10 μM) 1.25 µl
H2O 37.5 µl
NEBNext 2x PCR MasterMix 50 µl
Dec PCR product (pre-diluted 1:10) 5 µl
Code fwd primer (10 μM) 0.625 µl
Code2.2 rev primer (10 μM) 0.625 µl
H2O 18.75 µl
NEBNext 2x PCR MasterMix 25 µl
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20–40 μl per sample were pooled subsequently and purified using the NucleoSpin Gel and PCR Clean‐up kit 
(Macherey&Nagel).
Next-generation sequencing of barcodes. Barcode libraries were sequenced on an Ion Torrent Proton sequencer 
using the PI chip (Life Technologies). All template preparations and enrichments were done according to the 
manufacturer’s protocols for the Ion PI Template OT2 200 v3 kit (Life Technologies). Sequencing was done 
according to the manufacturer’s protocols for the Ion PI Sequencing 200 v3 kit. One PI chip delivered on average 
over 100 million raw reads.
Processing of the raw data was done using custom shell and R scripts. First, raw reads were split into individ-
ual samples using the 12 bp code and subsequently mapped to a reference barcode library using a local BLAST. 
Thereby, reads were counted and assigned to shRNAs and gene targets. Next, read counts were normalized to total 
read numbers per sample. If multiple barcodes are assigned to the same shRNA, corresponding read counts were 
summed. To control the correlation between replicates, similarities between all samples were estimated using 
pair-wise Pearson correlation coefficient and plotted as a heatmap with hierarchical clustering. Analysis was then 
continued by enhanced Z-score ranking or using the DESeq2 R package36.
For the enhanced Z-score analysis, normalized read counts of replicates were collapsed to mean count values 
and log2 transformed. Log2 ratios were calculated between stimulated and silenced samples and normalized to 
enhanced Z-scores. In order to collapse to gene level, the barcode/shRNA with the strongest effect towards the 
positive- (for negative regulators) or negative direction (for positive regulators) was selected to represent a certain 
gene.
The DESeq2 package allows testing for differential expression of a gene or in this case of a barcode. Therefore, 
normalized read count data with all replicates for the stimulated and silenced conditions was first processed using 
the DESeqDataSetFromMatrix() function. Next, data were analyzed using the DESeq() function which includes 
the Wald test for differential expression and correction by multiple testing using the Benjamini-Hochberg 
method51.
Orthogonal validation of selected hit shRNAs. Knockdown validation of selected hit shRNAs. Hit 
shRNAs were synthesized as two complementary oligonucleotides with AgeI and EcoRI overhangs, annealed and 
ligated into the pathScreener vector which has been digested with the same pair of restriction enzymes.
Target gene knockdown by hit shRNAs (see Supplementary Table S8) was validated by qRT-PCR. Therefore, 
primary cortical neurons were AAV infected on DIV6 with the pathScreener vector expressing individual hit 
shRNAs or a non-targeting control (NTC). Cultures were harvested in QIAzol cell lysis reagent (Qiagen) and 
total RNA was isolated with the Direct-zol RNA MiniPrep kit (Zymo). cDNA was reverse transcribed using the 
High-Capacity cDNA Reverse Transcription Kit (Thermo-Fisher) according to manufacturer’s instructions. Hit 
gene expression was quantified with intron-spanning gene specific primer pairs (see Supplementary Table S8), 
normalized to Rpl13a expression.
E-SARE luciferase reporter gene assay with individual hit shRNAs. Primary cortical neurons were AAV infected 
on DIV6 with the pathScreener vector expressing individual hit shRNAs or a non-targeting control (NTC). On 
DIV10, half of the cultures were silenced with 1 µM TTX, 100 µM D-APV (TTX cocktail) for 48 hrs. On DIV12, 
the remaining cultures were stimulated for 4 hours with 50 μM BIC, 100 μM 4-AP, 100 μM glycine, 1 μM strych-
nine (BIC cocktail). Subsequently, all cultures were lysed in passive lysis buffer (Promega). Lysate was transferred 
into white 96-well assay plates and measurement of luciferase bioluminescence was performed in a Mithras LB 
940 Microplate Reader (Berthold Technologies) as described previously26.
GCaMP5G imaging in primary neurons. For simultaneous shRNA and GCaMP5G expression, the pathScreener 
vector was cut with KpnI and EcoRI to remove the sensor cassette. At this site, an insert containing the human 
synapsin-1 promoter (Syn1p), the GCaMP5G ORF and the SV40 poly-adenylation site was ligated52.
Primary cortical neurons were infected on DIV6 with AAV expressing the hit shRNA and GCaMP5G. On 
DIV12, cultures were stimulated with 50 μM BIC, 100 μM 4-AP, 100 μM glycine, 1 μM strychnine and GCaMP5G 
fluorescence was imaged on a Zeiss Observer inverted microscope. Zeiss Zen microscope software was used for 
image analysis. Neuronal cell bodies were selected with ring-shaped regions-of-interest to measure grey intensity 
values over time. Raw values were normalized to average intensity values before stimulation to obtain normalized 
fluorescence values (F/F0). Two-way ANOVA was applied for statistical analysis (GraphPad Prism).
Reactome and KEGG pathway analysis. Pathway analysis of the top positive regulators from the enhanced 
Z-score ranking was done using the Reactome database and the KEGG database37,38. The Reactome analysis was 
done using the analysis function of the Reactome Pathway Browser (http://www.reactome.org/PathwayBrowser/) 
and the KEGG analysis was done via the WEBGESTALT homepage (http://bioinfo.vanderbilt.edu/webgestalt/).
Pubmed literature search. The batch Pubmed literature search was done using the CRAN R-package RISmed for 
the top 150 positive regulator hit genes based on the enhanced Z-score ranking.
Search string with MeSH terms associated with synapse-to-nucleus signalling:
(“gene symbol”[Title/Abstract] OR “alternative gene symbol”[Title/Abstract] AND (neurons[MeSH 
Terms]) AND (“synaptic transmission”[MeSH Terms] OR “calcium signaling”[MeSH Terms] OR “MAP Kinase 
Signaling System”[MeSH Terms] OR “Neuronal plasticity”[MeSH Terms] OR “Long-Term Potentiation”[MeSH 
Terms] OR “Long-term Synaptic Depression”[MeSH Terms] OR “Neuronal Outgrowth”[MeSH Terms]OR 
“excitability”[Title/Abstract]).
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Search string with MeSH terms associated with mental disorders:
(“gene symbol”[Title/Abstract] OR “alternative gene symbol”[Title/Abstract] AND (“neurons”[Mesh Terms]) 
AND (“Bipolar and Related Disorders”[MeSH Terms] OR “Mood Disorders”[MeSH Terms] OR “Neurocognitive 
Disorders”[MeSH Terms] OR “Schizophrenia Spectrum and Other Psychotic Disorders”[MeSH Terms]).
Cytoscape visualization. Protein-protein interactions were queried using the top 150 positive regulator hit genes 
in Bisogenet plugin from Cytoscape Apps which consolidates data from DIP, BIOGRID, HPRD, BIND, MINT 
and INTACT databases53,54. Protein identifiers were filtered for Homo sapiens and protein-protein interactions 
only with a max path length set to 2. The resulting network was further filtered to nodes with direct interaction to 
hit-list nodes. Edges between the non-hit-list nodes were removed to reduce the complexity of the network. Node 
attributes were added based on KEGG, Reactome genesets or Pubmed query results.
Data and Code Availability
Raw sequencing data and custom computer code for data analysis will be made available upon request.
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